NC1153

NC1153 is a selective JAK3 inhibitor that blocks IL-2-mediated STAT5a/b activation. This small molecule is a valuable research tool for studying T-cell signaling and has demonstrated efficacy in promoting allograft survival in preclinical transplantation models, offering a strategy to mitigate toxicity.